Macrogen's latest marketcap:
As of 07/07/2025, Macrogen's market capitalization has reached $116.72 M. According to our data, Macrogen is the 23686th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 116.72 M |
| Revenue (ttm) | 101.57 M |
| Net Income (ttm) | -5,369,993.24 |
| Shares Out | 10.84 M |
| EPS (ttm) | -0.53 |
| Forward PE | 21.66 |
| Ex-Dividend Date | 12/27/2024 |
| Earnings Date | 08/14/2025 |
Macrogen's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/07/2025 | ₩116.72 M | 2.18% | 23686 |
| 12/30/2024 | ₩164.45 B | -21.52% | 22644 |
| 12/28/2023 | ₩209.56 B | 8.16% | 20098 |
| 12/29/2022 | ₩193.74 B | -33.59% | 19640 |
| 12/30/2021 | ₩291.72 B | 9.42% | 17659 |
| 12/30/2020 | ₩266.61 B | 7.29% | 15672 |
| 12/30/2019 | ₩248.48 B | -15.36% | 14466 |
| 12/28/2018 | ₩293.57 B | -11.13% | 12567 |
| 12/28/2017 | ₩330.34 B | 13.07% | 12782 |
| 12/29/2016 | ₩292.16 B | -4.59% | 12080 |
Company Profile
About Macrogen, Inc.
Macrogen, Inc. is a leading provider of precision medicine and bio-engineering healthcare services, operating in Korea and internationally since 1997. Headquartered in Seoul, South Korea, the company offers a comprehensive range of advanced genetic and diagnostic solutions.
Core Services
- Personal Healthcare: Disease prediction, wellness genetic testing, and DTC (direct-to-consumer) genetic testing services.
- MyPETGENE: Genetic testing services tailored for companion animals.
- Clinical Services: Precision medicine, cancer risk genetic testing, NGS-based genetic panel labs, and GCLP services.
- Single Cell Expert Services: Single cell multi-omics, spatial transcriptome analysis, and single cell (In Situ/spatial) services.
Advanced Sequencing & Analysis
- Whole genome, whole exome, transcriptome, epigenome, and metagenome sequencing.
- Standard sequencing, identification, fragment analysis, and customized sequencing.
- Human ID services for forensic and research applications.
Additional Offerings
- Expression, genome, and epigenome microarray services.
- Proteomics Olink analysis.
- Gene synthesis, DNA/RNA oligo synthesis, and peptide synthesis.
- CRISPR knock-in/out, GEM, and mass production services.
With decades of expertise, Macrogen, Inc. continues to innovate in the field of genomics and personalized healthcare, serving both individual and institutional clients worldwide.
Frequently Asked Questions
-
What is Macrogen's (KOSDAQ-038290) current market cap?As of 07/07/2025, Macrogen (including the parent company, if applicable) has an estimated market capitalization of $116.72 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Macrogen (KOSDAQ-038290) rank globally by market cap?Macrogen global market capitalization ranking is approximately 23686 as of 07/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.